news-med.jpg

Chronos Therapeutics partners with Aptuit for addictive behaviour programmes

Oxford, UK - January 9, 2017 - Chronos Therapeutics Ltd (Chronos), the private biotech company focused on ageing diseases, brain and nervous system disorders, announced that they have partnered with a subsidiary of Aptuit Holdings LLC (Aptuit) for services related to Chronos’ programme targeting the addictive behaviours of binge eating and alcohol use disorders.
chronos logo.png
Read full press release from Chronos news site
(published January 9, 2017)

Topics: Corporate, Business